United States · FDA National Drug Code directory

duloxetine

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 49252-007_3fb45d3e-3fbc-8814-e063-6294a90a4a70
Product NDC: 49252-007
Form: CAPSULE, DELAYED RELEASE
Composition / generic term: duloxetine
Labeler: Inventia Healthcare Limited.
Marketing category: ANDA
Marketing start / end (source format): 20151205
Source listing expiry: 20261231

Source-listed ingredients

DULOXETINE HYDROCHLORIDE — 20 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (49252-007-10) · 49252-007-10
90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (49252-007-11) · 49252-007-11
60 CAPSULE, DELAYED RELEASE in 1 BOTTLE (49252-007-12) · 49252-007-12
1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (49252-007-18) · 49252-007-18
100 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK (49252-007-57) · 49252-007-57

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →